Menu

Merck & Co., Inc. (MRK) Q3 2026 Earnings Call Transcript
📰

Merck & Co., Inc. (MRK) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·22 days ago
#dBZC0owK
Long article (317 words) — no AI summary yet.
Reading 0:00
15s threshold

Merck & Co., Inc. ( MRK ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT

Company Participants

Peter Dannenbaum - Vice President of Investor Relations

Robert Davis - Chairman, President & CEO

Caroline Litchfield - Executive VP & CFO

Dean Li - Executive VP & President of Merck Research Laboratories

Jannie Oosthuizen - Executive VP and President of Oncology & MSD International

Brian Foard - Executive VP and President of Specialty, Pharma & Infectious Diseases

Conference Call Participants

Christopher Schott - JPMorgan Chase & Co, Research Division

Vamil Divan - Guggenheim Securities, LLC, Research Division

Michael Yee - UBS Investment Bank, Research Division

Courtney Breen - Bernstein Institutional Services LLC, Research Division

Akash Tewari - Jefferies LLC, Research Division

Daina Graybosch - Leerink Partners LLC, Research Division

Mohit Bansal - Wells Fargo Securities, LLC, Research Division

Steve Scala - TD Cowen, Research Division

Umer Raffat - Evercore ISI Institutional Equities,…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.